Literature DB >> 22826129

Megalin mediates transepithelial albumin clearance from the alveolar space of intact rabbit lungs.

Yasmin Buchäckert1, Sebastian Rummel, Christine U Vohwinkel, Nieves M Gabrielli, Benno A Grzesik, Konstantin Mayer, Susanne Herold, Rory E Morty, Werner Seeger, István Vadász.   

Abstract

The alveolo-capillary barrier is effectively impermeable to large solutes such as proteins. A hallmark of acute lung injury/acute respiratory distress syndrome is the accumulation of protein-rich oedema fluid in the distal airspaces. Excess protein must be cleared from the alveolar space for recovery; however, the mechanisms of protein clearance remain incompletely understood. In intact rabbit lungs 29.8 ± 2.2% of the radio-labelled alveolar albumin was transported to the vascular compartment at 37°C within 120 min, as assessed by real-time measurement of 125I-albumin clearance from the alveolar space. At 4°C or 22°C significantly lower albumin clearance (3.7 ± 0.4 or 16.2 ± 1.1%, respectively) was observed. Deposition of a 1000-fold molar excess of unlabelled albumin into the alveolar space or inhibition of cytoskeletal rearrangement or clathrin-dependent endocytosis largely inhibited the transport of 125I-albumin to the vasculature, while administration of unlabelled albumin to the vascular space had no effect on albumin clearance. Furthermore, albumin uptake capacity was measured as about 0.37 mg ml−1 in cultured rat lung epithelial monolayers, further highlighting the (patho)physiological relevance of active alveolar epithelial protein transport. Moreover, gene silencing and pharmacological inhibition of the multi-ligand receptor megalin resulted in significantly decreased albumin binding and uptake in monolayers of primary alveolar type II and type I-like and cultured lung epithelial cells. Our data indicate that clearance of albumin from the distal air spaces is facilitated by an active, high-capacity, megalin-mediated transport process across the alveolar epithelium. Further understanding of this mechanism is of clinical importance, since an inability to clear excess protein from the alveolar space is associated with poor outcome in patients with acute lung injury/acute respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22826129      PMCID: PMC3497570          DOI: 10.1113/jphysiol.2012.233403

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  56 in total

1.  Passage of aerosolized BSA and the nona-peptide dDAVP via the respiratory tract in young and adult rats.

Authors:  H G Folkesson; B R Weström; M Dahlbäck; S Lundin; B W Karlsson
Journal:  Exp Lung Res       Date:  1992 Sep-Oct       Impact factor: 2.459

2.  Clathrin-mediated endocytosis of FITC-albumin in alveolar type II epithelial cell line RLE-6TN.

Authors:  Ryoko Yumoto; Hiromi Nishikawa; Miho Okamoto; Hirokazu Katayama; Junya Nagai; Mikihisa Takano
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-12-16       Impact factor: 5.464

Review 3.  Signaling mechanisms regulating endothelial permeability.

Authors:  Dolly Mehta; Asrar B Malik
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

Review 4.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 5.  The role of megalin (LRP-2/Gp330) during development.

Authors:  Carolyn E Fisher; Sarah E M Howie
Journal:  Dev Biol       Date:  2006-06-08       Impact factor: 3.582

6.  Cisplatin-induced inhibition of receptor-mediated endocytosis of protein in the kidney.

Authors:  Mikihisa Takano; Naoki Nakanishi; Yasumi Kitahara; Yuki Sasaki; Teruo Murakami; Junya Nagai
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

7.  A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein.

Authors:  S E Williams; J D Ashcom; W S Argraves; D K Strickland
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

8.  Active transport and passive liquid movement in isolated perfused rat lungs.

Authors:  D H Rutschman; W Olivera; J I Sznajder
Journal:  J Appl Physiol (1985)       Date:  1993-10

9.  Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation.

Authors:  L H Wang; K G Rothberg; R G Anderson
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

Review 10.  Alveolar epithelium and Na,K-ATPase in acute lung injury.

Authors:  István Vadász; Stacy Raviv; Jacob I Sznajder
Journal:  Intensive Care Med       Date:  2007-05-25       Impact factor: 17.440

View more
  10 in total

1.  TGF-β inhibits alveolar protein transport by promoting shedding, regulated intramembrane proteolysis, and transcriptional downregulation of megalin.

Authors:  Luciana C Mazzocchi; Christine U Vohwinkel; Konstantin Mayer; Susanne Herold; Rory E Morty; Werner Seeger; István Vadász
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-07-13       Impact factor: 5.464

2.  Intracellular localization of polymyxins in human alveolar epithelial cells.

Authors:  Maizbha U Ahmed; Tony Velkov; Qi Tony Zhou; Alex J Fulcher; Judy Callaghan; Fanfan Zhou; Kim Chan; Mohammad A K Azad; Jian Li
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

3.  A Comparison of the Pharmacokinetics and Pulmonary Lymphatic Exposure of a Generation 4 PEGylated Dendrimer Following Intravenous and Aerosol Administration to Rats and Sheep.

Authors:  Gemma M Ryan; Robert J Bischof; Perenlei Enkhbaatar; Victoria M McLeod; Linda J Chan; Seth A Jones; David J Owen; Christopher J H Porter; Lisa M Kaminskas
Journal:  Pharm Res       Date:  2015-10-20       Impact factor: 4.200

4.  Mechanisms and modulation of microvesicle uptake in a model of alveolar cell communication.

Authors:  Daniel J Schneider; Jennifer M Speth; Loka R Penke; Scott H Wettlaufer; Joel A Swanson; Marc Peters-Golden
Journal:  J Biol Chem       Date:  2017-11-03       Impact factor: 5.157

5.  Human podocytes perform polarized, caveolae-dependent albumin endocytosis.

Authors:  Evgenia Dobrinskikh; Kayo Okamura; Jeffrey B Kopp; R Brian Doctor; Judith Blaine
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-26

6.  Restoration of Megalin-Mediated Clearance of Alveolar Protein as a Novel Therapeutic Approach for Acute Lung Injury.

Authors:  Christine U Vohwinkel; Yasmin Buchäckert; Hamza M Al-Tamari; Luciana C Mazzocchi; Holger K Eltzschig; Konstantin Mayer; Rory E Morty; Susanne Herold; Werner Seeger; Soni S Pullamsetti; István Vadász
Journal:  Am J Respir Cell Mol Biol       Date:  2017-11       Impact factor: 6.914

7.  In vitro evaluation of drug delivery behavior for inhalable amorphous nanoparticle formulations in a human lung epithelial cell model.

Authors:  Jianting Chen; Maizbha U Ahmed; Chune Zhu; Shihui Yu; Weisan Pan; Tony Velkov; Jian Li; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2021-01-21       Impact factor: 5.875

8.  Detrimental ELAVL-1/HuR-dependent GSK3β mRNA stabilization impairs resolution in acute respiratory distress syndrome.

Authors:  Olivia Hoffman; Nana Burns; István Vadász; Holger K Eltzschig; Michael G Edwards; Christine U Vohwinkel
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

9.  Participation of the SMAD2/3 signalling pathway in the down regulation of megalin/LRP2 by transforming growth factor beta (TGF-ß1).

Authors:  Felipe Cabezas; Pamela Farfán; María-Paz Marzolo
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

Review 10.  Acute Respiratory Distress Syndrome: Role of Oleic Acid-Triggered Lung Injury and Inflammation.

Authors:  Cassiano Felippe Gonçalves-de-Albuquerque; Adriana Ribeiro Silva; Patrícia Burth; Mauro Velho Castro-Faria; Hugo Caire Castro-Faria-Neto
Journal:  Mediators Inflamm       Date:  2015-11-12       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.